search icon

    Market Snapshot

    blog search icon

    ALX Oncology Holdings Inc. Stock Investors, Shareholders, Insiders and Outstanding Shares

    ALX Oncology Holdings Inc.

    (NASDAQ:ALXO)

    $9.31

    0.01 (0.11%)

    At Close: 4:00 PM

    $9.31

    0.00 (0.00%)

    After Market: 8:19 PM

    Shares & ShareHolders

    Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.

    Shares Outstanding

    40.75 Million

    Float

    30.01 Million

    Shortable

    Yes

    optionable

    Yes

    Shares Short

    4.4 Million

    Short % of shares outstanding

    10.79%

    Shares Short (Prior Month)

    4.56 Million

    13.51%

    Short of Float

    10.79%

    Short % of Shares Outstanding

    Top Institutional Holders

    A total of 2.20% of ALXO shares are owned by insiders. About - of ALXO shares are held by financial institutions. Fidelity Management & Research Co is the top corporate investor, holding 4.63 Million shares valued at $52.18 Million. A 11.36% stake in ALX Oncology Holdings Inc. is owned by the company. Logos Global Management LP owns 2.97 Million shares valued at $33.49 Million, which translates its holding of 7.29% of the stake in the company.

    Holder% StakeShares HeldTotal Value ($)Shares% Change in Portfolio
    Fidelity Management & Research Co11.36% 4,630,28252,183,278644,36016.17%
    Logos Global Management LP7.29% 2,971,35233,487,137-165,000-5.26%
    BlackRock Fund Advisors3.61% 1,469,05916,556,295-27,923-1.87%
    The Vanguard Group, Inc3.39% 1,381,60815,570,72279,3936.10%
    Wellington Management Co. LLP2.77% 1,128,10113,695,146-1,681,725-59.85%
    Eventide Asset Management LLC2.21% 902,00010,165,540902,000-
    Redmile Group LLC1.85% 752,0978,476,133-14,700-1.92%
    Cormorant Asset Management LP1.75% 712,0798,025,13000%
    HBM Partners AG1.47% 600,3946,766,440-5,000-0.83%
    Invus Public Equities Advisors LL1.23% 500,0005,635,00000%

    ALX Oncology Holdings Inc. Insiders

    Among the ALXO insiders holding of 0.07% of the stake in company, PONS JAUME, President & CEO, holds the largest shares of 539,746. LETTMANN JASON, Director, is the second largest ALXO insider with ownership of 285,956 shares. LSV ASSOCIATES, LLC,10% Owner, stands third with possession of 285,956 shares of that stake.

    InsiderDesignationShares Held
    PONS JAUMEPresident & CEO539,746
    LETTMANN JASONDirector285,956
    LSV ASSOCIATES, LLC10% Owner285,956
    RANDOLPH SOPHIAChief Medical Officer270,253
    PINTO SHELLYVP, Finance and CAO62,097
    GARCIA PETER SChief Financial Officer53,723

    Insider Transaction Summary (6 Months)

    SHARES

    TRANS

    PURCHASES

    0

    0

    Sales

    0

    0

    Net ShareN/A

    0

    0

    NO. of Shares Held

    0

    0

    % Net ShareN/A

    -

    0.00%

    Frequently Asked Questions

    icon

    How many institutions own ALXO stock?

    A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own ALXO shares is 172, representing N/A of the company's common stock.

    icon

    Who are the major shareholders selling ALX Oncology Holdings Inc. stock?

    Logos Global Management LP, in the last quarter, reduced its stake in ALXO by -5.26% restricting it's holding to 2.97 Million shares of worth nearly $33.49 Million. BlackRock Fund Advisors also lessened -1.87% of the ALXO shares from its portfolio, reducing its holding to 1.47 Million shares of worth $16.56 Million. Wellington Management Co. LLP also shunned ALXO shares holding by -59.85% last quarter which brought its holding to 1.13 Million shares worth $13.7 Million.

    icon

    Investors who are buying ALXO stock?

    As per its latest 13F filing, Fidelity Management & Research Co increased its stake in ALXO by 16.17% in the last quarter. The institutional holder raised its holding to 4.63 Million shares having worth more than $52.18 Million. The Vanguard Group, Inc also added 6.10% more shares of ALXO to its portfolio, raising its holding to 1.38 Million shares of worth $15.57 Million. Cormorant Asset Management LP also increased its ALXO shares holding by 0% which brought its holding to 712.08 Thousands shares worth $8.03 Million.

    icon

    ALXO's major insiders: who are they?

    The insider with the most stakes in ALXO is PONS JAUME , a President & CEO at the company. Additionally, ALXO stock is highly held by Director LETTMANN JASON and 10% Owner LSV ASSOCIATES, LLC among others.

    icon

    Did an insider recently sell ALXO stock?

    Company executives, directors, and other insiders own 2.2 percent of ALX Oncology Holdings Inc.'s stock. Within the last six months, there have been 0 transaction(s) in which ALXO insiders have sold stock, totaling 0 shares. Insiders that have sold shares include

    icon

    Which insider recently purchased ALXO stock?

    There have been no transaction(s) during the past 6-months in which ALXO insiders have bought stock N/A.

    icon

    How much of ALXO does insiders own?

    Around 896.5 Thousands ALX Oncology Holdings Inc. shares are held by insiders, which represents about 2.20% of ALXO Stock.

    icon

    Who is the insider with the largest stake?

    ALXO President & CEO, PONS JAUME holds the largest portfolio of the company's shares. ALXO shares owned by Levinson total nearly 539.75 Thousands.

    icon

    Which institution holds the most shares in ALXO?

    Fidelity Management & Research Co is the largest institutional owner in ALXO which holds 4.63 Million shares worth $52.18 Million or 11.36% of the total ALXO shares outstanding followed by Logos Global Management LP with ownership of 2.97 Million shares representing 7.29% of the ALXO ownership. BlackRock Fund Advisors, Inc is the third largest stakeholder with 1.47 Million shares or 3.61% of the ownership worth more than $16.56 Million.

    icon

    Is ALX Oncology Holdings Inc. stock optionable?

    Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the ALXO is concerned, it is a stock which is optionable.

    icon

    Is there a short position on ALXO's shares?

    Number of ALXO shares short as of 2022-10-13 was 4.4 Million. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

    icon

    About how many outstanding ALXO shares are there?

    As of today, 40.75 Million shares of ALXO are outstanding.

    icon

    Is there many float in ALX Oncology Holdings Inc. stock?

    Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, ALXO has 30.01 Million shares in float.

    icon

    ALXO short ratio: what is it?

    Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for ALXO was N/A as of 2022-10-13.